speb/financial-data huggingface dataset:
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2741520000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2885460000.00
HESTERBIO.NS income_statement (annual, 2023-03-31) — Total Expenses: 2245260000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3814200000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4423740000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2327240000.00
HESTERBIO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 3310000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 33870000.00
HESTERBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -3270000.00
HESTERBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -3270000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 150840000.00
HESTERBIO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 788960000.00
HESTERBIO.NS income_statement (annual, 2023-03-31) — Write Off: 3430000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1520840000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 3045460000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 258560000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 786450000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1406900000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 175070000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -9000000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 337130000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 8506865.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Basic EPS: 22.20
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 126660000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1554240000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -243970000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -243970000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 53780000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 123070000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 129950000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -68530000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 123070000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 92290000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 32990000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -64440000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Payable: -37270000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 5290000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 36740000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -5160000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2917930000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1701420000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1101820000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2146150000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 420000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 569140000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 569560000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 24560000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1054720000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 7600000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 0.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Depreciation: 171740000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 171740000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 171740000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 171740000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 8506865.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 22.20
HESTERBIO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 188890000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 4420000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — EBIT: 410720000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — EBITDA: 582460000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 1570000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 123070000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -260930000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 469300000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 237860000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -280000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 49020000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 39320000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 795450000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5503010000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Gross Profit: 1943640000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Interest Expense: 91190000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 91190000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Interest Income: 19070000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 19070000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -149410000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 18940000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Inventory: 755810000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 5307930000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -226060000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 299270000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 204740000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 136360000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 53360000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1820860000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1874220000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 204740000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -229660000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 299270000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 25340000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2053090000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 110820000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Minority Interests: -22770000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Net Debt: 2266930000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -1210000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income: 188890000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 188890000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 211660000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 188890000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 188890000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 319530000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 211660000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -75220000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1580000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -299990000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -24920000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -75220000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 260000000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -1580000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 4096110000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 550000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -275070000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2878610000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 22520000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 536660000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 74110000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25340000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 35240000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 575530000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Normalized Income: 184299568.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 481830000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Operating Income: 422800000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 3045460000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 204560000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 32130000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 2832860000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 39320000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 45820000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 110940000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 10000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 536660000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 13610000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 430230000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 127640000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 57900000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 97090000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 6880000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -12050000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Payables: 390620000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7600000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 327560000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Pretax Income: 319530000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 6900000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 114690000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 1101820000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 171740000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 23310000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 23310000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -504730000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 29970000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2150890000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 550000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 256040000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 305060000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 8506865.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -275070000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Special Income Charges: 6930000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2917930000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2878610000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 2339568.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Tax Provision: 107870000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.34
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 19320000.00
HESTERBIO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -116660000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 6623470000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 4738790000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2443780000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 3028750000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Total Expenses: 2622660000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3594720000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 4477320000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 2540000000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 3100000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 24560000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 6930000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 6930000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 126000000.00
HESTERBIO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1091430000.00
HESTERBIO.NS income_statement (annual, 2024-03-31) — Write Off: 5120000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 247180000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 941170000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 354160000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 49370000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 135630000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 352900000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 3018300000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1711260000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 2221900000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 841260000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 841260000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1268130000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 6810000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 39920000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 4056440000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 672000000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 5409150000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 354160000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 49370000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1549590000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1598960000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 28450000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 124180000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2255220000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 4056440000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2978380000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 75370000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 197920000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 64290000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2933230000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 39920000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 20080000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 534250000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2345180000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 57910000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 217270000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 271450000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 3018300000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2978380000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 6692500000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4567890000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2440220000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 3142480000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3550020000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 4470600000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 2281890000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 24270000.00
HESTERBIO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 953770000.00
HESTERBIO.NS income_statement (quarterly, 2024-12-31) — Interest Income: 38120000.00
HESTERBIO.NS income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 38120000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1632300000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 461780000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 3111020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 819250000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 294190000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 294190000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 731810000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 731810000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1561030000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1561030000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 175070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 175070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -53710000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -53710000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 2490000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 396330000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 396330000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 8506865.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7093407.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Basic EPS: 32.31
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.82
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 123070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1551750000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1551750000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -205910000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -205910000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 54750000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 54750000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 55870000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 55870000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 65490000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 65490000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -51680000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 55870000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 55870000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 52040000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 14230000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -19930000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Payable: 36510000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 17150000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 99450000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -62090000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 3142550000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3142550000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1782670000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1782670000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1026290000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 207420000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1951740000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1951740000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 744070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 744070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 744070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 744070000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 40170000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 40170000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1251840000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1251840000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 10290000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 10290000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Depreciation: 165530000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 168020000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 168020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 41760000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 168020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 41760000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 8506865.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7093407.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 32.31
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.82
HESTERBIO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 274880000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 12910000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 3780000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 3780000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — EBIT: 479110000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — EBIT: 93650000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — EBITDA: 647130000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 135410000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -5110000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 55870000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -517170000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 426220000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 426220000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 439200000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 4860000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 67920000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 66570000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 66570000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 785520000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 785520000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 5670510000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5670510000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Gross Profit: 2084730000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 611830000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Interest Expense: 83400000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 56200000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 83400000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 56200000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Interest Income: 20370000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 20370000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -131270000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 8260000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Inventory: 703770000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 703770000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 5220300000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5220300000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -190030000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 340510000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 340510000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 136360000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 136360000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 54750000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 54750000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1333680000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1333680000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1388430000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1388430000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -313440000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 340510000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 340510000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 27530000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 27530000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2140510000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2140510000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 124010000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 124010000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Minority Interests: -13380000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -2500000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2021880000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2021880000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -7670000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income: 274880000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income: 12910000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 274880000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 12910000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 288260000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 15410000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 274880000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 12910000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 274880000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 12910000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 395710000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 288260000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 15410000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -67890000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -56200000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 4880000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -331160000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -313440000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -67890000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -56200000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 4880000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 4109480000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 4109480000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 2740000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -17720000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3075980000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3075980000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 532210000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 532210000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 59330000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 59330000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 27530000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 27530000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 49410000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 49410000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 651990000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 135410000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Normalized Income: 278420329.03
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 12910000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 645110000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Operating Income: 452430000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Operating Income: 150050000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 3111020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 819250000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 184710000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 184710000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 32280000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 32280000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 3057480000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 3057480000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 66570000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 66570000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 53290000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 53290000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 95740000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 25680000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 25680000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 532210000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 532210000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 8650000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -69500000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 466020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 278110000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 115750000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 115750000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 59220000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 59220000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 106270000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 106270000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 9620000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 9620000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Other Special Charges: 4860000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Payables: 413720000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 413720000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10290000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10290000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 307710000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 307710000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Pretax Income: 395710000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 37450000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 44710000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 123650000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 123650000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1026290000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 207420000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 168020000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 41760000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 26520000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 26520000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -331160000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 16320000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 16320000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2370860000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2370860000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2740000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 282820000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 350740000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 8506865.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -17720000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Special Income Charges: -4860000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 3142550000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3142550000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3075980000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3075980000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -1319670.97
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Tax Provision: 107450000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 22040000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.27
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 20370000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 20370000.00
HESTERBIO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -114710000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 6533850000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 6533850000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 4476230000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4476230000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2132500000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2132500000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 3266560000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3266560000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Total Expenses: 2658590000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 669200000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3267290000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3267290000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 4582110000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4582110000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2015450000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2015450000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 4860000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 40170000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 40170000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -4860000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4860000.00
HESTERBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 100610000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 100610000.00
HESTERBIO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 699900000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 699900000.00
HESTERBIO.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 430110000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 841050000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 8087555.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 20.33
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 224620000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 41820000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 41820000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 8087555.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 20.33
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — EBIT: 219970000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 261790000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 616430000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 18100000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 18100000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -8540000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 172960000.00